Cargando…

Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development

Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it i...

Descripción completa

Detalles Bibliográficos
Autores principales: Amenyogbe, Nelly, Kollmann, Tobias R., Ben-Othman, Rym
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442244/
https://www.ncbi.nlm.nih.gov/pubmed/28596951
http://dx.doi.org/10.3389/fped.2017.00111
_version_ 1783238368263405568
author Amenyogbe, Nelly
Kollmann, Tobias R.
Ben-Othman, Rym
author_facet Amenyogbe, Nelly
Kollmann, Tobias R.
Ben-Othman, Rym
author_sort Amenyogbe, Nelly
collection PubMed
description Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it is not surprising that even minor alterations during this co-development can have profound consequences. Scrutiny of existing data regarding pre-, peri-, as well as early postnatal modulators of newborn microbiota indeed suggest strong associations with several immune-mediated diseases with onset far beyond the newborn period. We here summarize these data and extract overarching themes. This same effort in turn sets the stage to guide effective countermeasures, such as probiotic administration. The objective of our review is to highlight the interaction of host immune ontogeny with the developing microbiome in early life as a critical window of susceptibility for lifelong disease, as well as to identify the enormous potential to protect and promote lifelong health by specifically targeting this window of opportunity.
format Online
Article
Text
id pubmed-5442244
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54422442017-06-08 Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development Amenyogbe, Nelly Kollmann, Tobias R. Ben-Othman, Rym Front Pediatr Pediatrics Human existence can be viewed as an “animal in a microbial world.” A healthy interaction of the human host with the microbes in and around us heavily relies on a well-functioning immune system. As development of both the microbiota and the host immune system undergo rapid changes in early life, it is not surprising that even minor alterations during this co-development can have profound consequences. Scrutiny of existing data regarding pre-, peri-, as well as early postnatal modulators of newborn microbiota indeed suggest strong associations with several immune-mediated diseases with onset far beyond the newborn period. We here summarize these data and extract overarching themes. This same effort in turn sets the stage to guide effective countermeasures, such as probiotic administration. The objective of our review is to highlight the interaction of host immune ontogeny with the developing microbiome in early life as a critical window of susceptibility for lifelong disease, as well as to identify the enormous potential to protect and promote lifelong health by specifically targeting this window of opportunity. Frontiers Media S.A. 2017-05-24 /pmc/articles/PMC5442244/ /pubmed/28596951 http://dx.doi.org/10.3389/fped.2017.00111 Text en Copyright © 2017 Amenyogbe, Kollmann and Ben-Othman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Amenyogbe, Nelly
Kollmann, Tobias R.
Ben-Othman, Rym
Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_full Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_fullStr Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_full_unstemmed Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_short Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development
title_sort early-life host–microbiome interphase: the key frontier for immune development
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442244/
https://www.ncbi.nlm.nih.gov/pubmed/28596951
http://dx.doi.org/10.3389/fped.2017.00111
work_keys_str_mv AT amenyogbenelly earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment
AT kollmanntobiasr earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment
AT benothmanrym earlylifehostmicrobiomeinterphasethekeyfrontierforimmunedevelopment